Company Financials
Neurones Financials
Euro
business
Neurones Company Profile
Main Stock Listing
Euronext: NRO
Market Capitalization €1.06 Billion as of Jan. 1, 2025
Market Cap History
Valuations Metrics as of Jan. 25, 2025
| Trailing PE | 21.93 |
| Forward PE | 19.84 |
| Price to Sales TTM | €1.37 |
| Price to Book MRQ | €3.03 |
| Enterprise to Revenue | 1.15 |
| Enterprise to EBITDA | 10.86 |
Financial Reports as of Dec. 31, 2023
Financials
| Fiscal Year Ends | 2023-12-31 |
| Most Recent Quarter | 2023-12-31 |
| Profit Margin | 6.26% |
| Operating Margin | 9.19% |
| Return on Assets TTM | 7.06% |
| Return on Equity TTM | 14.87% |
Income Statement
| Revenue TTM | €774,913,984 |
| Revenue per Share TTM | €31.94 |
| Quarterly Revenue Growth | 9.20% |
| Gross Profit TTM | €366,502,016 |
| EBITDA | €97,366,000 |
| Net Income to Common TTM | €48,489,000 |
| Diluted EPS TTM | €1.99 |
| Quarterly Earnings Growth YoY | -3.60% |
Balance Sheet
| Total Cash MRQ | €268,115,008 |
| Total Cash per Share MRQ | €11.05 |
| Total Debt MRQ | € |
| Total Debt to Equity MRQ | 11.71 |
| Current Ratio MRQ | 2.25 |
| Book Value per Share MRQ | €14.41 |
Cash Flow
| Operating Cash Flow TTM | €62,181,000 |
| Levered Free Cash Flow TTM | €42,636,124 |
NRO Stock Info as of Jan. 25, 2025
Stock Statistics
| Shares Outstanding | 24,273,000 |
| Float Shares | 8,799,562 |
| Avg 10 Volume | 4,250 |
| Avg 30 Volume | None |
| Shares Short | None |
| Short Ratio | |
| Short % of Shares | % |
| % Held by Insiders | 69.89% |
| % Held by Institutions | 13.70% |
Stock Price Summary
| Beta | 0.56 |
| Fifty Two Week Low | €39.45 |
| Fifty Two Week High | €48.15 |
| Fifty Two Week Change | -3.22% |
| Day 50 MA | €44.51 |
| Day 200 MA | €44.37 |
Dividends and Splits
| Forward Annual Dividend Rate | €4.80 |
| Forward Annual Dividend Yield | 11.02% |
| Trailing Annual Dividend Rate | €1.20 |
| Trailing Annual Dividend Yield | 2.76% |
| Payout Ratio | 60.30% |
| Dividend Date | |
| Ex Dividend Date | 2024-06-12 |
| Last Split Factor | |
| Last Split Date |